Author:
Xu Ke,Han Bin,Bai Yang,Ma Xiu-Ying,Ji Zhen-Ni,Xiong Yao,Miao Shi-Kun,Zhang Yuan-Yuan,Zhou Li-Ming
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology
Reference53 articles.
1. International Agency for Research on Cancer. http://ci5.iarc.fr .
2. Chen, W., Zheng, R., Zeng, H., Zhang, S. & He, J. Annual report on status of cancer in China.2011. Chin. J. Cancer Res. 27, 2–12 (2015).
3. People’s Republic of China health and Family Planning Commission of medical affairs authority, Chinese Medical Association Cancer Society branch. Chinese standard of diagnosis and treatment of colorectal cancer. Chin. Arch. Gen. Surg. 9, 506–523 (2015).
4. Cunningham, D. et al. Colorectal cancer. Lancet 375, 1030–1047 (2010).
5. Hurwitz, H. et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N. Engl. J. Med 350, 2335–2342 (2004).
Cited by
69 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献